Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan and Hydrochlorothiazide Factorial Trial in Japanese Patients
NCT00153049Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of telmisartan in essential hypertension (9 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change from baseline in supine diastolic blood pressure at trough at 8 weeks. Started Jun 2004; status: completed.
02
Drugs
telmisartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00153049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153049.